Carl Zeiss Meditec AG (CZMWY) Stock

About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG functions as a prominent global medical technology firm, conducting its operations across Germany, other European nations, the United States, and various Asian markets. Its business is organized into two principal divisions: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment provides an array of products and solutions tailored for the diagnosis and therapeutic management of ocular conditions, including specialized systems and essential consumables for cataract, retinal, and refractive surgical procedures. This division serves ophthalmologists, optometrists, and medical and surgical professionals in hospitals and ambulatory surgery centers. The Microsurgery segment focuses on delivering advanced visualization tools vital for intricate surgical interventions, additionally supplying specialized solutions for ear, nose, and throat (ENT), plastic and reconstructive, dental, and spinal surgeries. This segment supports a diverse group of medical practitioners across various disciplines, as well as healthcare institutions. Established in 1846 and headquartered in Jena, Germany, the company operates as a subsidiary of Carl Zeiss AG.

Carl Zeiss Meditec AG is headquartered in DE.

Carl Zeiss Meditec AG (CZMWY) stock trades at $35.36 with a market capitalization of $3.10B. The stock is valued at a price-to-earnings (P/E) ratio of 22.43, price-to-book of 1.27, price-to-sales of 1.01. Over the past 52 weeks the stock has ranged between $26.65 and $56.32, and currently trades 37.2% below its 52-week high. It pays a dividend yielding 1.80%.

On profitability, Carl Zeiss Meditec AG generates a return on equity (ROE) of 4.27%, return on capital employed of 5.73%, an operating margin of 6.15%, a net profit margin of 3.41%.

Official website: www.zeiss.com/meditec-ag/de/home.html